BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 4 hours ago Atmus Welcomes Heath Sharp to Board of Directors 6 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 6 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 2 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 2 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 2 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 3 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 3 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 4 hours ago Atmus Welcomes Heath Sharp to Board of Directors 6 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 6 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago
ADVERTISEMENT

Pfizer inc (PFE) Q1 2023 Earnings Call Transcript

Pfizer inc (NYSE:PFE) Q1 2023 Earnings Call dated May. 02, 2023.   Corporate Participants: Christopher Stevo — Senior Vice President, Investor Relations Officer Dr. Albert Bourla — Chairman and…

Pfizer Inc. (PFE) Q2 2022 Earnings Call Transcript

Pfizer Inc.  (NYSE: PFE) Q2 2022 earnings call dated Jul. 28, 2022 Corporate Participants: Christopher Stevo — Senior Vice President and Chief Investor Relations Officer Dr. Albert…